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Brain-derived neurotrophic factor (BDNF) and its receptor TrkB regulate synaptic plasticity.
TrkB triggers three downstream signaling pathways; Phosphatidylinositol 3-kinase (PI3K),
Phospholipase Cγ (PLCγ) and Mitogen activated protein kinases/Extracellular signal-
regulated kinases (MAPK/ERK).We previously showed two distinct mechanisms whereby
BDNF-TrkB pathway controls trafﬁcking of PSD-95, which is the major scaffold at excitatory
synapses and is critical for synapse maturation. BDNF activates the PI3K-Akt pathway
and regulates synaptic delivery of PSD-95 via vesicular transport (Yoshii and Constantine-
Paton, 2007). BDNF-TrkB signaling also triggers PSD-95 palmitoylation and its transport to
synapses through the phosphorylation of the palmitoylation enzyme ZDHHC8 by a protein
kinase C (PKC; Yoshii et al., 2011). The second study used PKC inhibitors chelerythrine as
well as a synthetic zeta inhibitory peptide (ZIP) which was originally designed to block
the brain-speciﬁc PKC isoform protein kinase Mζ (PKMζ). However, recent studies raise
concerns about speciﬁcity of ZIP. Here, we assessed the contribution ofTrkB and its three
downstream pathways to the synaptic distribution of endogenous PSD-95 in cultured
neurons using chemical and genetic interventions. We conﬁrmed that TrkB, PLC, and
PI3K were critical for the postsynaptic distribution of PSD-95. Furthermore, suppression
of MAPK/ERK also disrupted PSD-95 expression. Next, we examined the contribution of
PKC. While both chelerythrine and ZIP suppressed the postsynaptic localization of PSD-
95, RNA interference for PKMζ did not have a signiﬁcant effect. This result suggests that
the ZIP peptide, widely used as the “speciﬁc” PKMζ antagonist by many investigators
may block a PKC variant other than PKMζ such as PKCλ/ι. Our results indicate that TrkB
regulates postsynaptic localization of PSD-95 through all three downstream pathways, but
also recommend further work to identify other PKC variants that regulate palmitoylation
and synaptic localization of PSD-95.
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INTRODUCTION
The Brain-derived neurotrophic factor (BDNF) and its receptor
TrkB are critical for maturation of both excitatory (Gorski et al.,
2003; Wirth et al., 2003; Chakravarthy et al., 2006; Tanaka et al.,
2008; Kaneko et al., 2012) and inhibitory neurons (Hanover et al.,
1999; Huang et al., 1999). In the visual cortex, BDNF increases
2 weeks after birth largely due to the visual activity after eye
opening (Castren et al., 1992). BDNF-TrkB signaling regulates
excitation–inhibition balance (Schinder et al., 2000) and facilitates
activity-dependent formation of neuronal circuits (Cabelli et al.,
1995, 1997; Heimel et al., 2010) as well as critical period closure of
ocular dominance (Hanover et al., 1999; Huang et al., 1999).
In excitatory neurons, BDNF-TrkB signaling regulates den-
dritic growth (Xu et al., 2000), spine maturation, stabilization
(Gorski et al., 2003; Wirth et al., 2003; Chakravarthy et al., 2006;
Tanaka et al., 2008; Kaneko et al., 2012), and long-term poten-
tiation (LTP; Kang and Schuman, 1995; Figurov et al., 1996;
Patterson et al., 1996; Tanaka et al., 1997; Frerking et al., 1998;
Gottschalk et al., 1998; Huber et al., 1998). BDNF-TrkB signaling
also plays a critical role in the development of synapses by regulat-
ing the transport of the membrane associated guanylate kinase
the post-synaptic density protein PSD-95. In the visual path-
way of rodents upon eye-opening, PSD-95, which is the major
scaffolding protein at mature glutamate synapses (Yoshii and
Constantine-Paton, 2007; Yoshii et al., 2011), is transported to
young synaptic contacts by BDNF/TrkB. SAP102, the dominant
MAGUK in neonatal period, does not require an activation of
BDNF-TrkB signaling for its postsynaptic localization (Yoshii and
Constantine-Paton, 2007) and moves to early synapses in associa-
tion with the NR2B subunit GluN2B (Washbourne et al., 2004). In
our previous work, we reported two distinct mechanisms whereby
the BDNF-TrkB pathway controls trafﬁcking of PSD-95. BDNF
activates the Phosphatidylinositol 3-kinase (PI3K)-Akt pathway
and triggers synaptic delivery of PSD-95 via vesicular transport
(Yoshii and Constantine-Paton, 2007). BDNF-TrkB signaling is
also necessary for PSD-95’s initial association with membranes.
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It initiates PSD-95 palmitoylation through the phosphorylation
of the palmitoylation enzyme ZDHHC8 by Phospholipase Cγ
(PLC γ) and a protein kinase C (PKC; Yoshii et al., 2011). Here
we verify our previous observations on the roles of the PI3K-
Akt and PLC γ- PKC pathways in the transport of PSD-95 to
synapses. We also extend these analyses of BDNF-TrkB signaling
to the role of the third pathway downstream of TrkB activation:
namely, the Mitogen activated protein kinase/Extracellular signal-
regulated kinase (MAPK/ERK) pathway. Finally, in light of recent
publications indicating that ZIP, the reagent we used to block the C
kinase PKMζ, is not speciﬁc for PKMζ in LTP, (Lee et al., 2013;Volk
et al., 2013) we test whether another PKC may also be involved in
the palmitoylation of PSD-95.
MATERIALS AND METHODS
ANIMALS
TrkBF616A mice carrying a modiﬁcation in the ATP binding site of
this kinase (Chen et al., 2005) were kindly provided by Dr. David
Ginty. Wild type (WT) C57BL6 mice were obtained from Charles
River Laboratories. All manipulations were performed in accord
with the guidelines of the MIT-IACUC.
PRIMARY NEURON CULTURE, LIPOFECTION, IMMUNOCYTOCHEMISTRY
Occipital cortices of E15.5 mouse brains were dissected, digested
with a solution containing papain and DNase for 25 min. Cells
were dissociated using ﬁre polished glass pipets and plated at
the density of 0.5 × 106 cells per cm2 after counting with a
hemocytometer. Coverslips were coated with laminin and poly-
D-lysine. Transfections of DNA constructs encoding either small
interfering RNA (siRNA) against PKMζ or its scrambled sequence
(kindly provided by Dr. Richard Huganir, Johns Hopkins Univer-
sity) was performed at day in vivo (DIV) 8 using Lipofectamine
2000 (Invitrogen) according to the manufacturer’s protocol. On
DIV15, cultured neurons were treated with the following reagents.
1NM-PP1 to block activation of TrkB or its control construct
Bph-PP1 (kindly provided by Dr. Kevan Shokat, UCSF). U73122
(1 μM), Chelerythrine (2.5 μM), PD98059 (50 μM), and Wort-
mannin (100 nM) were used to block PLC, PKCMAPK, and PI3K,
respectively, and were purchased from Sigma-Aldrich. The PKMζ
inhibitory pseudosubstrate ZIP (myr-SIYRRGARRWRKL-OH)
and scrambled peptide (myr-RLYRKRIWRSAGROH; Pastalkova
et al., 2006) were synthesized in the MIT Biopolymers Laboratory.
Twenty-four hours after each exposure, cultures were ﬁxed
with 4% paraformaldehyde (15min). Neurons were permeabilzed
with 0.3% TritonX-100 for 5 min and washed. Cultures were
blocked with 9% BSA (1 h), and incubated with an antibody
for PSD-95 (Neuromab #K28/43, 1:1000) at room temperature
overnight. After washing with PBS (3x), cultures were incubated
with secondary antibody Alexa Fluor 488 (Molecular Probes) for
2 h.
Images were captured using a 60x objective on a Nikon PCM
2000 confocal microscope and a 6–8 μm, Z-series, of optical
sections were taken at intervals of 0.5 μm. 12/4 μm areas contain-
ing isolated typical secondary dendritic branches from pyramidal
neurons were selected. For each area, a threshold was set to
optimally represent PSD-95 puncta and exclude diffuse label in
dendritic shafts (See Figure 2A middle and bottom rows). The
same threshold was applied to all neurons in the set of cul-
tures in each experiment. Immunocytochemical experiments were
repeated twice for each treatment condition. Eight cells from eight
culture dishes were imaged. Using ImageJ, total pixel intensity
was calculated as the sum of each pixel number multiplied by its
intensity as measured above threshold for each cell. This value was
then averaged across all dendritic segments sampled in the exper-
iment and presented as total pixel intensity of PSD-95 puncta.
Averaged cell body intensity was also measured in ImageJ by man-
ually selecting soma (yellow circles in Figure 2A) and applying the
Measure function in ImageJ. Subsequently, total pixel intensity of
PSD-95 puncta was divided by the averaged cell body intensity for
normalization.
TUNEL ASSAY
FragELTM DNA Fragmentaion Detection Kit (Calbiochem) was
used for the TUNEL assay. The procedures were performed
according to the manufacturer’s instructions. Cell numbers in
250 μm × 250 μm were counted and the apoptosis incidence
was calculated by dividing the TUNEL (+) cell number with total
cell number.
STATISTICS
A Student’s t-test was used for comparison of two groups. One-
way ANOVA with post hoc Tukey tests were used for comparisons
of more than two groups. p < 0.05 were considered signiﬁcant
and indicated as ∗ in graphs. p < 0.01 and p < 0.001 are indicated
as ∗∗ and ∗∗∗. Numeric data are presented as average ±SD in the
“Results” section. Error bars in graphs represent SEM.
RESULTS
We previously studied trafﬁcking of PSD-95 in dendrites of cul-
tured occipital cortical neurons using Fluorescent recovery after
photobleaching (FRAP) and showed that bath application of
BDNF as well as a BDNF-coated beads facilitated transport of
GFP-tagged PSD-95 in dendrites (Yoshii and Constantine-Paton,
2007). Furthermore, BDNF application resulted in an increase of
the intensity of PSD-95 immunolabeled puncta.
In the current experiments we ﬁrst examined the postsynaptic
distribution of PSD-95 in dissociated cultured neurons prepared
fromE15.5 cortices of TrkBF616A mice. Thismouse strain has a sin-
gle amino acid mutation in the intracellular domain of the TrkB
receptor allowing the signaling activities of the receptor to be selec-
tively blocked by the synthetic compound 1NM-PP (Chen et al.,
2005). At DIV 15, we treated neurons with either 1NM-PP1 or
the “control” non-blocking molecule Bph-PP1for 24 h. Using the
TUNEL assay, we examined the incidence of apoptotic cells at vari-
ous concentrations of 1NM-PP1 (Figure 1).We found that the cell
death incidence was not signiﬁcantly different at 1 (0.036 ± 0.020;
total of 123 apoptotic cells out of 3430 cells in 33 images) and 3μM
(0.036 ± 0.021; total of 244 apoptotic cells out of 6652 cells in 33
images) as compared with no treatment (0.033 ± 0.025; total of
132 apoptotic cells out of 3961cells in 33 images) (ANOVA relative
the no treatment group or the control Bph-PP1 group p = 0.96
and 0.79, respectively). We determined 9 μMof 1NM-PP1 is toxic
because 40% of cells are TUNEL+. Consequently, PSD-95 puncta
intensity was accessed using 1NM-PP1at 3 μM or less. First, we
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FIGURE 1 | Apoptosis rate of neurons that undergoTrkB signaling
inhibition using the chemical genetic approach. Ratio’s of Tunel signal
positive cells to total cell number (∼3,500–6,600 cells examined in
250 μm × 250 μm from eight cultures for each condition) are presented.
Error bars represent SEM.
measured the averaged pixel intensity of the cell bodies (encir-
cled areas with yellow dashed lines in Figure 2A) and found that
PSD-95 expression level was slightly but signiﬁcantly decreased in
cultures treated with 2 (41.5 ± 7.6; N = 8) or 3 μM (41.5 ± 8.7;
N = 8) of 1NM-PP1 as compared with 1μM(50.4± 10.1; N = 8)
or Bph-PP1 control (49.8 ± 10.5; N = 8). Therefore, we normal-
ized the total pixel intensity of PSD-95 puncta by the intensity of
soma. First we selected the deﬁned area (4 μm × 12 μm squares
in Figure 2A) of secondary dendritic branches and acquired total
pixel intensities of PSD-95 puncta (See Materials and Methods;
Yoshii and Constantine-Paton, 2007; Yoshii et al., 2011). These
crude PSD-95 total pixel intensities were signiﬁcantly reduced in
neurons treated with 1NM-PP1 (1 μM; 57,800 ± 23,200; N = 16)
as compared to neurons without treatment (23,100 ± 11,600;
N = 16; Figure 2C; ANOVA between 1 μM and the no treat-
ment groups; p = 0.0043). Next, each intensity value was divided
by averaged somal PSD-95 intensity of the same neuron. Normal-
ized PSD-95 total pixel intensities remained signiﬁcantly reduced
in neurons treatedwith 1NM-PP1 as compared to control neurons
treated with Bph-PP1 (Figure 2D; ANOVA between 1 μMand the
control groups; p = 0.0089). Higher concentration of 1NM-PP1
caused more suppression of PSD-95 puncta (ANOVA between 1
and 3 μM groups; p = 0.043; Figure 2D).
To examine each of the three TrkB downstream signaling path-
ways, we used antagonists against PLC, PI3K, and MAPK/ERK
(Figure 3). First, we examined the PSD-95 immunolabel intensi-
ties of the somata and found that the blocker of the MAPK/ERK
(38.3 ± 6.2; N = 8) but not two other signaling pathways (PI3K;
49.7 ± 7.4; N = 8 and PLC; 45.5 ± 4.7; N = 8) resulted in a
decrease of somal PSD-95 expression (Control; 49.9± 10.5;N = 8;
Figure 3A). Next we examined PSD-95 total puncta intensities
in dendrites (Figure 3B). As expected from our previous works,
blockade of PLC with U73122 (31,700 ± 10,200; N = 16) or PI3K
withWortmannin (23,100 ± 11,600; N = 16) caused suppression
of PSD-95 puncta intensities as compared to the no treatment
controls (50,900 ± 35,100; N = 16; ANOVA; p = 0.042 and 0.025,
respectively). Furthermore inhibition of the MAPK/ERK pathway
with PD98059 (21,300 ± 19,500; N = 16) resulted in a decrease
of PSD-95 puncta intensities (ANOVA to the no treatment group;
p = 0.0017). Normalization to averaged cell body intensity also
conﬁrmed that all three downstream pathways were involved in
the normal postsynaptic delivery and/or expression of PSD-95
(Figure 3C).
We previously showed that activation of PLC by BDNF-TrkB
signaling is necessary for PSD-95 palmitoylation and its transport
to synapses. This mechanism depends on the phosphorylation
of the palmitoylation enzyme ZDHHC8 by a PKC (Yoshii et al.,
2011), which is activated by PLC. In that study, we used the PKC
inhibitor Chelerythrine as well as a synthetic PKMζ inhibitory
peptide ZIP which was originally thought to speciﬁcally block
this brain-speciﬁc PKC isoform (Ling et al., 2002). We conﬁrmed
that ZIP treatments resulted in a reduction of PSD-95 puncta
intensity (25,100 ± 13,900; N = 16; Figure 4A; ANOVA to con-
trol; p = 0.02) as was also reported in the hippocampus (Shao
et al., 2012), subsequent to our original ﬁnding in the visual
cortex. Chelerythrine treatment also showed a similar result as
ZIP treatment (28,000 ± 13,000; N = 16; ANOVA to control;
p = 0.035).
However, in contrast to earlier experiments suggesting that ZIP
was a speciﬁc PKMζ antagonist (Ling et al., 2002), recent studies
using PKMζ knockout mice have not shown the expected LTP
defect even though they did conﬁrm that ZIP suppressed the
LTP response (Lee et al., 2013; Volk et al., 2013). These reports
raised the concern about the speciﬁcity of ZIP for PKMζ. Conse-
quently, we tested PKMζ directly by suppressing its expression
using RNAi. We transfected DNA constructs encoding siRNA
against PKMζ or the scrambled sequence at DIV8 and examined
it at DIV16. RNAi for PKMζ did not have a signiﬁcant effect on
postsynaptic localization of PSD-95 (30,600 ± 21,200; N = 16)
as compared to neurons transfected with the scrambled sequence
construct (33,600 ± 20,300; N = 16; Student’s t-test; p = 0.73;
Figure 4B).
DISCUSSION
SYNAPTIC EXPRESSION OF PSD-95 DEPENDS ON PKC BUT NOT PKMζ
In our previous in vitro study, we applied BDNF to neurons
expressing PSD-95 tagged with GFP and saw an increase in puncta
intensity in 60 min (Yoshii and Constantine-Paton, 2007). We
also used FRAP and pharmacological treatments and showed
that the BDNF effect on vesicular transport of PSD-95 requires
the PI3K/Akt pathway (Yoshii and Constantine-Paton, 2007).
In the following in vivo study, we used TrkBF616A mice and
showed that our synchronized eye-opening regime, which trig-
gers PSD-95 redistribution to synapses in rats (Yoshii et al., 2003),
also activates TrkB in visual cortex and regulates the synaptic
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FIGURE 2 | 1NM-PP1 suppresses punctate distribution of PSD-95
dose-dependently in TrkBF616A neurons. (A) The top row shows
representative neurons immunostainted with anti-PSD-95. Typical
secondary dendritic branches analyzed are shown in 48 μm2 rectangles
in the middle row. These branches are processed after the thresholding
shown in the bottom row. The scales in the top and bottom rows
show 10 and 1 μm, respectively. (B) Graph showing averaged PSD-95
intensities in somata. (C) Graph showing quantiﬁcation of PSD-95
puncta total pixel intensities. Note that all three concentrations of
1NM-PP1 result in reduced total PSD-95 puncta intensity. (D) In this
graph, PSD-95 puncta intensities are normalized to somal PSD-95
intensities. In each condition, 16 branches from eight cells (chosen from
the two different dissociations) were analyzed. Error bars represent
SEM.
localization of PSD-95. Furthermore, the TrkB activation is nec-
essary for palmitoylation of PSD-95 in somata through PLC,
PKC, and the palmitoylation enzyme ZDHHC8 (Yoshii et al.,
2011). In the current study on cultured visual cortical neu-
rons using the same pharmacological intervention, we conﬁrmed
that postsynaptic distribution of PSD-95 depends on BDNF-TrkB
signaling, and that PI3K and PLC are necessary for increased
PSD-95 at synaptic puncta. However, even though ZIP sup-
pressed PSD-95 puncta intensity, knockdown of PKMζ using
RNAi has no effect on postsynaptic expression of PSD-95. This
result is consistent with recent reports showing PKMζ knock-
out mice do not show an abnormal LTP response (Lee et al.,
2013; Volk et al., 2013). One possibility for these LTP results,
suggested by Lisman (2012), is that the concentration of ZIP
is too high and causes non-speciﬁc inhibition (Lisman, 2012).
Alternatively, ZIP may not be a speciﬁc PKMζ inhibitor rather
it may also interact with other PKC variants such as another
atypical PKC (PKCλ/ι; Lee et al., 2013; Volk et al., 2013). These
results necessitated revising our previous interpretation (Yoshii
et al., 2011). The current results suggest that a PKC variant
other than PKMζ should be present in the developing visual
cortex and is likely to phosphorylate the palmitoylation enzyme
ZDHHC8.
MAPK/ERK IS INVOLVED IN SYNAPTIC EXPRESSION OF PSD-95
The currentwork also indicates that theMAPK/ERKpathwayplays
a role in the synaptic expressionof PSD-95 as its inhibitor PD98059
signiﬁcantly suppresses PSD-95 intensities of the soma as well as
dendrite. This is consistent with the previous report showing that
BDNF-induced increase in dendritic spine density is mediated
by MAPK/ERK1/2 (Alonso et al., 2004). MAPK/ERK regulates
protein-synthesis dependent plasticity by increasing phosphory-
lation of eukaryotic initiation factor 4E (eIF4E), the 4E-binding
protein 1 (4E-BP1) and ribosomal protein S6 (Kelleher et al., 2004;
Klann and Dever, 2004), therefore this pathway may directly ini-
tiate translation of PSD-95 gene either in the cell bodies of young
neurons or in response to local activity in dendritic spines.
Brain-derived neurotrophic factor also activates the elonga-
tion of translation, which is mediated by PI3K and MAPK/ERK
(Inamura et al., 2005). These two kinases turn off the eukaryotic
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FIGURE 3 | PSD-95 puncta intensities in neurons that are treated with
inhibitors of signaling molecules downstream ofTrkB. Neurons are
treated with blockers of the PLC (U73122, 1 μM), MAPK (PD98059, 50 μM),
or PI3K (Wortmannin, 100 nM). Quantiﬁcation was performed in the same
manner as data presented in Figure 2. The graphs show averaged PSD-95
intensities in somata (A), total pixel intensities of PSD-95 puncta (B), and
puncta intensities normalized to somal intensities (C). In each condition, 16
branches from eight cells were analyzed. Error bars represent SEM.
FIGURE 4 | Zeta inhibitory peptide (ZIP) but not PKMζ knockdown
causes suppression in PSD-95 puncta intensity. (A) Neurons are treated
with ZIP (1 μM), PKC (Chelerythrine, 2.5 μM), or the scrambled ZIP peptide
(1 μM). (B) Neurons are transfected with DNA constructs encoding siRNA
for PKMζ or the scrambled sequence. In both experiments, 16 branches
from eight cells were analyzed. Error bars represent SEM.
elongation factor 2 kinase (eEF2K), in two parallel mechanisms.
In turn, the suppression of eEF2K results in an increase of
dephosphorylated and active eukaryotic elongation factor 2
(eEF2; Wang et al., 2001). This laboratory previously showed
that NMDAR activation and visual activity rapidly induces phos-
phorylation of eEF2 at the synapse (Scheetz et al., 1997). This
suppresses synthesis of most proteins but facilitates CaMKII
synthesis. In rat dentate gyrus, BDNF application in vivo
has been shown to induce LTP via ERK pathway, increase
phosphorylation of eEF2 at non-synaptic sites and enhance
expression of CaMKII-α and Arc (Kanhema et al., 2006). Fur-
thermore, Worley and his colleagues obtained similar results
for eEF2 phosphorylation via activation of mGluR5 in the hip-
pocampus where the general shutdown of protein synthesis at the
synapse signiﬁcantly increased Arc/Arg3 translation (Park et al.,
2008).
Another potential mechanism is that MAPK/ERK may be
involved is mRNA transport. PSD-95 transcripts have been shown
to exist in dendrites and interact with the fragile X mental retar-
dation protein (FMRP). This enhances stability of the PSD-95
transcript and represses its translation during mRNA transport
(Zalfa et al., 2007). A recent study shows that FMRP forms a
complex with CYFIP1, a newly identiﬁed 4E-binding protein,
and represses translation during mRNA transport (Napoli et al.,
2008). BDNFcan release this translational repression (Napoli et al.,
2008). Whether MAPK/ERK meditates BDNF-dependent protein
synthesis via translation and/or mRNA transport awaits future
studies.
Brain-derived neurotrophic factor application also regulates
transcription via MAPK/ERK which phosphorylates the cAMP-
response element binding transcription factor (CREB) at ser-
ine133 residue (Bonni et al., 1995, 1999; Finkbeiner et al.,
1997; Shaywitz and Greenberg, 1999; Pizzorusso et al., 2000;
Ying et al., 2002). Interestingly, CREB can activate the Bdnf
gene through promoter IV (Hong et al., 2008) and amplify
BDNF-dependent synapse maturation. Therefore, we predict that
MAPK/ERK regulates either or both transcription and trans-
lation of PSD-95. However, it remains to be studied whether
CREB directly activates transcription of PSD-95 itself or up-
regulates BDNF, which further facilitates posttranscriptional reg-
ulation of PSD-95, i.e., translation, palmitoylation, or vesicular
transport.
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CONCLUSION
It is now clear that the increases in PSD-95 at synapses are
mediated by all three signaling pathways downstream of TrkB.
They are involved in various processes regulating protein expres-
sion. MAPK/ERK could regulate transcription through CREB and
other transcription factors. MAPK/ERK and PI3K-Akt pathway
play major roles in translation (Kelleher et al., 2004; Klann and
Dever, 2004). The PI3K pathway also facilitates vesicular transport
of PSD-95 from ER to Golgi apparatus, then along microtubule.
PSD-95 is synthesized in the cytoplasm and requires palmitoy-
lation to become attached to membranes and to get delivered
to postsynaptic membranes. This post-translational modiﬁcation
is regulated by BDNF-TrkB signaling via PLC–PKC. These same
mechanisms are likely to regulate BDNF-dependent long-term
plasticity. Furthermore, PSD-95 itself and its interactionwithTrkB
signaling have been implicated in various brain diseases, especially
neurodevelopmental disorders such as autism spectrum disorders
(Tsai et al., 2012), Angelman syndrome (Cao et al., 2013), and
schizophrenia (Mukai et al., 2008).
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